Markets: 2026-09-04 Close
The major indexes, sector leaders and laggards, and 8 verified stock movers from the 2026-09-04 session.
Published 2026-09-07 · Session 2026-09-04 · AI-assisted research and writing
A sourced recap of the previous completed U.S. trading session. Closing moves are not real-time quotes.
The market tape
- **S&P 500 (SPX)**: -0.38%, closed at 7,718.6 - **Nasdaq Composite (COMP)**: -0.29%, closed at 26,506.99 - **Dow Jones Industrial Average (DJIA)**: -0.51%, closed at 53,414.25 - **Russell 2000 (RUT)**: +0.25%, closed at 2,975.65
Sector leaders and laggards
- Leaders: Information Technology +0.71%; Industrials +0.41%; Utilities +0.04% - Laggards: Consumer Discretionary -1.34%; Communication Services -1.18%; Health Care -1.04%
Notable movers
lululemon athletica inc. (LULU) -17.38%
Fiscal second-quarter revenue declined, Americas demand weakened and management cut full-year revenue and earnings guidance for a second time. The selloff erased billions in value and highlighted weakening premium-apparel demand, merchandising problems and the challenge facing the incoming chief executive.
Sources: primary catalyst · catalyst corroboration · closing quote
Fair Isaac Corporation (FICO) -16.68%
FHFA Director Bill Pulte directed Fannie Mae and Freddie Mac to approve all lenders to use rival VantageScore, expanding a rollout previously limited to 50 lenders. The federal action directly challenges FICO's dominant mortgage-scoring economics and triggered an unusually large policy-driven valuation shock.
Sources: policy catalyst · closing quote
Tesla, Inc. (TSLA) -5.92%
Tesla reversed the prior session's Cybercab enthusiasm after the Austin launch underwhelmed investors and NHTSA opened an audit into whether the steering-wheel-free vehicle complied with federal safety standards. The move tested a central element of Tesla's autonomy valuation thesis and followed a direct federal intervention immediately after commercial deployment.
Sources: primary regulatory catalyst · catalyst and closing-move corroboration · closing quote
Quanex Building Products Corporation (NX) +22.23%
Fiscal third-quarter results showed $501.8 million of sales, improved consolidated margins, adjusted earnings materially above consensus and $42.25 million of debt repayment. A large earnings-driven revaluation in a housing-products supplier despite a rate-sensitive macro backdrop.
Sources: primary catalyst · closing quote · catalyst corroboration
Guidewire Software, Inc. (GWRE) -19.93%
Shares reset sharply after fiscal fourth-quarter results as investors focused on fiscal 2027 guidance implying slower growth, despite quarterly revenue and adjusted earnings exceeding expectations. A nearly 20% decline in a large vertical-software company illustrates the market's intolerance for decelerating forward growth at premium valuations.
Sources: primary catalyst · closing quote
UiPath Inc. (PATH) -16.63%
Although UiPath beat its quarterly guidance and modestly raised its full-year revenue outlook, net-new annual recurring revenue slowed sequentially and investors remained unconvinced that AI products were accelerating growth. The reaction shows investors distinguishing between AI positioning and measurable subscription acceleration in enterprise software.
Sources: primary catalyst · catalyst analysis · closing quote
Equifax Inc. (EFX) -6.37%
FHFA Director Bill Pulte expanded VantageScore availability to all Fannie Mae and Freddie Mac lenders while accusing the major credit bureaus of overcharging and considering additional changes to credit-report requirements. Equifax jointly owns VantageScore but also faces regulatory and pricing pressure on credit reports, producing a complex negative read-through from the policy announcement.
Sources: policy catalyst and move corroboration · closing quote
Belite Bio, Inc. (BLTE) +13.16%
The stock extended gains following a September 2 commercial update covering FDA priority review of tinlarebant for Stargardt disease, a February 12, 2027 target action date and launch preparations. The move reflects increasing investor confidence in a potential first-in-class rare-eye-disease launch ahead of a defined regulatory decision.
Sources: recent catalyst · closing quote
Stock spotlight
No mover met the source-confidence threshold for a detailed spotlight.
_MacroShed Markets is informational analysis, not investment advice._
Sources
- lululemon athletica inc. Announces Second Quarter Fiscal 2026 Results
- Lululemon forecast cut hits shares, underscores challenge for next CEO
- lululemon athletica Stock Price History
- US official directs Fannie Mae, Freddie Mac to approve VantageScore for all lenders
- Fair Isaac Stock Price History
- NHTSA Opens Investigation into Tesla Cybercab Self-Certification Following Austin Deployment
- Feds open probe into Musk's steering-wheel-free taxis
- Tesla Stock Price History
- Quanex Building Products Announces Third Quarter 2026 Results
- Quanex Building Products Stock Price History
- Why Quanex Stock Skyrocketed by 22% on Friday
- Guidewire Announces Fourth Quarter and Fiscal Year 2026 Financial Results
- Guidewire Software Stock Price History
- UiPath Reports Second Quarter Fiscal 2027 Financial Results
- Why is UiPath stock sliding today?
- UiPath Stock Price History
- US directs Fannie Mae, Freddie Mac to approve VantageScore for all lenders
- Equifax Stock Price History
- Belite Bio Investor Update
- Belite Bio Stock Price History
- Why Asana Shares Are Sliding Today
- Asana Stock Price History
- Autodesk Stock Price History Charts
- Autodesk Stock Price
- Aehr Test Systems Stock Price, Quote and News
- Market Movers for September 4, 2026
- Historic Price Lookup
- Tyra Biosciences Stock Price History